SummaryAustralian researchers found that honeybee venom, particularly its compound melittin, can rapidly kill aggressive breast cancer cells like triple-negative and HER2-positive types while sparing healthy ones. The venom disrupts cancer cell growth signals and, when combined with chemotherapy, enhances treatment effectiveness. Scientists call the discovery promising but stress further clinical testing is needed.